Fireside Chat: TPD – Where Are We Now & Where Are We Going?
Time: 8:30 am
day: Day One AM
Details:
A sit down conversation with Kymera Therapeutics’ Chief Executive Officer, Nello Mainolfi on his thoughts on strategy, current roadblocks, and future directions for the targeted protein degradation field
